載入...
Tumor-associated antigen specific CD8(+) T cells in hepatocellular carcinoma – a promising target for immunotherapy
Immunotherapy is a promising treatment option for patients with hepatocellular carcinoma (HCC). Indeed, CD8(+) T-cell responses against various tumor antigens occur in these patients. However, these antitumoral T cells show a severely impaired effector function. Several immunosuppressive mechanisms...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292268/ https://ncbi.nlm.nih.gov/pubmed/25941604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954919 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|